Mustang Bio, Inc. (MBIO): Price and Financial Metrics
MBIO Price/Volume Stats
| Current price | $1.25 | 52-week high | $65.00 |
| Prev. close | $1.29 | 52-week low | $1.01 |
| Day low | $1.23 | Volume | 48,000 |
| Day high | $1.28 | Avg. volume | 423,116 |
| 50-day MA | $1.25 | Dividend yield | N/A |
| 200-day MA | $7.08 | Market Cap | 5.47M |
MBIO Stock Price Chart Interactive Chart >
Mustang Bio, Inc. (MBIO) Company Bio
Mustang Bio Inc., a clinical-stage biopharmaceutical company, focuses on the development and commercialization of novel cancer immunotherapy products based on the chimeric antigen receptor engineered T cell technology. Its lead programs include MB-101 for the treatment of brain cancer that is in Phase I trials; and MB-102, a therapeutic agent in acute myeloid leukemia, which is in Phase I trials. The company was founded in 2015 and is based in New York, New York. Mustang Bio Inc. is a subsidiary of Fortress Biotech, Inc.
MBIO Latest News Stream
| Event/Time | News Detail | ||||||||
|---|---|---|---|---|---|---|---|---|---|
| Loading, please wait... | |||||||||
MBIO Price Returns
| 1-mo | 9.65% |
| 3-mo | -15.54% |
| 6-mo | -87.01% |
| 1-year | -83.87% |
| 3-year | -99.75% |
| 5-year | -99.96% |
| YTD | -85.88% |
| 2024 | -86.89% |
| 2023 | -77.21% |
| 2022 | -76.21% |
| 2021 | -56.14% |
| 2020 | -7.23% |